VBI Vaccines, Inc. - Ordinary Shares (VBIV) Social Stream
VBI VACCINES INC (VBIV) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering VBI VACCINES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-01 | 3 | $9 | $8 | $8.5 | $0.293 | 2801.02% |
| 2022-03-07 | 3 | $9 | $6 | $7.666 | $0.293 | 2516.38% |
| 2022-05-11 | 2 | $8 | $6 | $6.666 | $0.293 | 2175.09% |
| 2022-08-08 | 3 | $8 | $6 | $6.666 | $0.293 | 2175.09% |
| 2022-08-09 | 3 | $7 | $5 | $6 | $0.293 | 1947.78% |
| 2022-11-11 | 3 | $7 | $2 | $5 | $0.293 | 1606.48% |
| 2023-03-13 | 2 | $6 | $2 | $4 | $0.293 | 1265.19% |
| 2023-03-14 | 2 | $2 | $2 | $2 | $0.293 | 582.59% |
The Trend in the Analyst Price Target
Over the past 16 months, VBIV's average price target has gone down $6.
VBIV reports an average of 616.31% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-09 | 3 | 8 | 6 | 6.666 | 1.060 | 528.87% |
| 2022-08-08 | 3 | 8 | 6 | 6.666 | 1.040 | 540.96% |
| 2022-11-11 | 2 | 6 | 2 | 4.000 | 0.597 | 570.02% |
| 2022-11-11 | 2 | 7 | 2 | 5.000 | 0.597 | 737.52% |
| 2023-03-14 | 2 | 2 | 2 | 2.000 | 0.365 | 447.95% |
VBIV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 1 | 1 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 43 weeks, VBIV's average broker recommendation rating worsened by 0.5.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- VBIV has a greater upside potential (average analyst target price relative to current price) than 879.94% of all US stocks.
- VBI VACCINES INC's average analyst price target is higher than 47.87% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, VBI VACCINES INC's number of analysts covering the stock is higher than 61.32% of them.
- In the context of Pharmaceutical Products stocks, VBI VACCINES INC's variance in analysts' estimates is lower than -137.74% of them.
Stocks similar to VBI VACCINES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ATNF, ATNX, and GTHX.
View All Top Stocks by Price Target
Is VBIV a Buy, Hold or Sell? See the POWR Ratings now!